Sign in
Not yet recruitingNo phase

Personalized Education and Pain Response in Chronic Pancreatitis

Key facts

Who runs it
Asian Institute of Gastroenterology, India
Where
India1 site in 1 countryChoose a country to see its sites
Trial code
Status
Not yet recruiting
People taking part
114 people, planned
Started
1 Aug 2025
Expected to end
31 Dec 2026
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Personalised education
Record updated
30 July 2025

Who can take part

Age
18 years to 60 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Chronic pancreatitis of at least 3 years
  • At least 3 episodes of pain in the past 3 months
  • Age 18-60yrs
  • Both genders

Who cannot take part

  • Active substance use (alcohol, smoking, smokeless tobacco, Illicit drugs)
  • Psychiatric illness at enrolment or during follow-up, and/or concomitant intake of antidepressants and neuromodulators
  • Pancreatic cancer
  • Other chronic diseases (including end organ damage related to diabetes)
  • Acute pancreatitis episode at the time of enrolment
  • Adverse life event in the family in the past 6 months
  • Pregnancy and lactation

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 60 years old?

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Pain mechanisms in chronic pancreatitis (CP) are heterogeneous and includes nociception, pancreatic neuropathy and central neuropathy/neuroplasty. These mechanisms could occur simultaneously in variable proportions and could explain why several patients develop recurrence of pain even after being treated by all the currently available modalities, such as antioxidants, endoscopic therapies and surgery.

Read full original descriptionShow less

In the studies by the investigators over the past 2 years, they observed that persistent pain in these patients was associated with varying grades of depression and poor quality of life. This was accompanied by alteration in the metabolites in the brain (anterior cingulate cortex, prefrontal cortex, hippocampus, and basal ganglia) as evidenced in magnetic resonance spectroscopy (MRS) of the brain. These areas in the brain are responsible for pain modulation, long-term pain memory and emotional responses to pain.

When the investigators counselled these patients and explained their disease and possible outcomes based on their own clinical course, imaging and treatment response (personalized education/counselling), they reported significant improvement in depression, quality of life parameters and, interestingly, also in pain. Further, there were changes in the metabolite parameters in the brain on MRS after personalized counselling/education that was more similar to that of healthy controls.

This led to our hypothesis that better understanding of the disease and its outcomes by the patients could improve their coping capabilities and increase their pain thresholds. This could augment the pain responses of these patients to the other therapeutic modalities.

We will conduct this single blinded, placebo controlled, randomized controlled trial on patients with documented CP of over 3 years duration, who had at least 3 episodes of abdominal pain of over the past 3 months.

The 2 groups in the trial

  • Personalised educationTreatment being tested

    1. Greetings. 2. Recording of demographic, clinical (disease related), nutritional, laboratory, and treatment related data. 3. Administration of questionnaires. 4. Inquiring patient's perception of their disease. 5. Explaining the patient about their disease in general followed by specific aspects and possible outcomes in the context of their perception, clinical aspects, questionnaire, and imaging data. In addition, the general treatment plan will be explained. 6. Address all queries from the patient and care givers.

  • Standard communicationNo study treatment, for comparison

    1. Greetings. 2. Recording of demographic, clinical (disease related), nutritional, laboratory, imaging and treatment related data. 3. Administration of questionnaires. 4. Explaining the general treatment plan. 5. Address general treatment related queries from the patient and care givers.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Impact of Personalized Education on Pain Response in Patients With Chronic Pancreatitis (PEPCP)
Criteria questions
Built from NCT04654377, who can take part
Record updated
30 July 2025